
This study assessed the excess bleeding risk during initial and extended anticoagulant treatment for venous thromboembolism (VTE) in 36,115 VTE cases and matched controls. During initial treatment, 1.07% of VTE patients bled, with females and the elderly at higher risk. During extended treatment (6 months to 5 years), bleeding risk was lower and not influenced by age or sex, with no significant differences.
Like
Save
Share